跳至主要内容
临床试验/EUCTR2008-000815-13-DE
EUCTR2008-000815-13-DE进行中(未招募)不适用

Analysis of cerebral, renal, peripheral, and retinal hemodynamics in adults with type 2 diabetes before, during, and after administration of pioglitazone or placebo.

Technical University Munich0 个研究点开始时间: 2008年4月3日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Written informed consent
  • Age 18 - 95 years
  • Fasting blood sugar (FBS) > 200 mg/dl and / or HbA1c > 5,9% or antidiabetic treatment
  • Adequate bilateral temporal bone windows for sufficient TCD examination and symmetrical perfusion of the middle cerebral artery (MCA)
  • Cardio- / cerebrovascular disease
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • General Exclusion Criteria
  • Participation in another pharmacologic study in the last 30 days
  • Known or possible pregnancy or breastfeeding
  • Cognitive impairment or other reasons interfering with patient compliance
  • Known malignancy in the last 5 years
  • Specific Exclusion Criteria
  • Hemodynamically relevant stenoocclusive disease of the extracranial and / or intracranial cerebral arteries diagnosed by doppler sonography
  • TIA or stroke in the last 3 months
  • Carotid endarteriectomy or angioplasty in the last 3 months
  • Insulin dependency
  • Diabetic ketoacidosis
  • Body mass index (BMI) > 35 kg/m2
  • Premedication with thiazolidindiones
  • Start of treatment with statins in the last 3 months
  • Start of treatment with angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers in the last 3 months
  • Known drug intolerance against thiazolidindiones
  • Known drug intolerance against indicator substances (PAH, IN)
  • Known drug intolerance against tropicamide
  • Known liver disease (GOT and / or GPT > 2.5 x upper normal limit)
  • Known renal insufficiency (serum creatinine > 1.2 mg/dl and / or creatinine clearance < 30 ml/min according to the Cockroft formula)
  • Known microalbuminuria
  • Known anaemia (haemoglobin < 11 g/dl (male), < 10 g/dl (female))
  • Known heart insufficiency (NYHA I-IV)
  • Advanced pulmonary disease
  • Known angle-closure glaucoma

研究者

发起方
Technical University Munich

相似试验